News
Daily weight-loss pill may work as well as Ozempic and could replace injections
A new weight-loss pill taken daily could compete with injections like Ozempic, new research suggests. Patients, who all were obese and suffered from type 2 diabetes, took orforglipron for nine months as part of a trial, losing an an average of 16lbs.
Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...
Woman's World on MSN4d
Doctors Say This Is the #1 Diet to Lose Weight and Keep It Off for GoodI f you've noticed the number on the scale creeping upwards or your clothes getting snug, you likely already know that weight ...
Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...
Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.
Cardio burns more calories per session, while weight training offers sustained metabolic benefits by building lean muscle.
Millions of dollars in a new state budget proposal could allow for the return of GLP-1 coverage for some state employees.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback